For example, a high level of B-Myb/MYBL2 expression in breast cancer is a clinically useful predictor of tumor recurrence and decreased patient survival (Amatschek et al., 2004; Paik et al., 2004; Thorner et al., 2009). Here, MYBL2 is linked to breast carcinoma.